In this application we are requesting funds for the purchase of a ThermoScientific a next-generation Q-LTQ Orbitrap. We are requesting this instrument because its capabilities are well suited for bottom-up, middle-down and top-down protein characterization, high-sensitivity quantitative proteomics of limited samples and post- translational modification analysis. The requested next-generation hybrid Orbitrap has several key improvements over the current LTQ Orbitrap Elite that allow it to achieve better performance: 1) Mass selecting quadrupole available to select ions for Orbitrap or ion trap analysis, 2) Parallel operation of both ion trap and Orbitrap mass analyzers allowing for significantly increased scan rate, 3) HCD cell for ion accumulation in single ion or multiplexed modes, 4) Full flexibility of CID, HCD and ETD dissociations at any stage of MSn analysis, 5) Ultrahigh field Orbitrap with advanced transient processing, 6) Novel, high performance front-end ETD source and dedicated internal mass calibration. These improvements along with reduced overhead result in a high-resolution data acquisition rate greater than other designs without sacrificing sensitivity or dynamic range. The faster combined MS1 and MS2 scan rates of the requested next-gen Orbitrap are essential for LC- MS/MS with high efficiency ultra-high pressure LC separations, resulting in reduced proteomic experiment time without loss of data quality. This requested next-generation Q-LTQ Orbitrap will be critical to support the needs of several Major Users that performing large-scale proteomics on human tissue where samples are limited and sensitivity and throughput are key requirements.

Public Health Relevance

The Ohio State University is requesting funds for the purchase of a high-sensitivity, high-resolution nextgeneration Q-LTQ Orbitrap mass spectrometer. This instrument will be used for bottom-up, middle-down and top-down protein characterization, spectral count relative quantitation of LC-MS/MS of human tissue biopsies and labile post-translational modification analysis.

National Institute of Health (NIH)
Office of The Director, National Institutes of Health (OD)
Biomedical Research Support Shared Instrumentation Grants (S10)
Project #
Application #
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Birken, Steven
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Ohio State University
Schools of Medicine
United States
Zip Code
Dorayappan, Kalpana Deepa Priya; Wanner, Ross; Wallbillich, John J et al. (2018) Hypoxia-induced exosomes contribute to a more aggressive and chemoresistant ovarian cancer phenotype: a novel mechanism linking STAT3/Rab proteins. Oncogene 37:3806-3821
Yin, Xin; Ying, Dong; Lhomme, S├ębastien et al. (2018) Origin, antigenicity, and function of a secreted form of ORF2 in hepatitis E virus infection. Proc Natl Acad Sci U S A 115:4773-4778
Loewen, Jennifer M; Cianciolo, Rachel E; Zhang, Liwen et al. (2018) Concurrent renal amyloidosis and thymoma resulting in a fatal ventricular thrombus in a dog. J Vet Intern Med 32:1160-1165
Singh, Kanhaiya; Pal, Durba; Sinha, Mithun et al. (2017) Epigenetic Modification of MicroRNA-200b Contributes to Diabetic Vasculopathy. Mol Ther 25:2689-2704
Branson, Owen E; Freitas, Michael A (2016) Tag-Count Analysis of Large-Scale Proteomic Data. J Proteome Res 15:4742-4746
Martin, E C; Qureshi, A T; Dasa, V et al. (2016) MicroRNA regulation of stem cell differentiation and diseases of the bone and adipose tissue: Perspectives on miRNA biogenesis and cellular transcriptome. Biochimie 124:98-111